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● Melanoma is a prevalent form of skin cancer 
found in melanin-producing cells 
(melanocytes) caused by ultraviolet (UV) 
radiation leading to uncontrolled cell growth. 
● Current Melanoma treatments include 
chemotherapy and radiation, both of which 
are risky procedures that have side effects 
and negatively impact a patient’s quality of 
life.
● Drug therapies of Melanoma include 
Antineoplastic Agents such as Ipilimumab 
(Yervoy®), Nivolumab (Opdivo®), and 
Dabrafenib (Tafinlar®), these therapies have 
been shown to be quite expensive.
● Recently, the use of essential oils (EOs)  has 
become a form of alternative therapy for 
melanoma treatment due to the wide array of 
chemical compounds that reduce 
inflammation, inhibit proliferation, induce 
apoptosis,  and/or prevent melanogenesis. 
Conclusion
Introduction
● A systematic review was conducted, as 
shown in the diagram illustrated below. It 
incorporated searches from databases to 
perform a retrospective analysis on many 
EOs.
● The search results were narrowed down to 
30 research articles using various 
techniques, including in vitro, in vivo, and 
gas chromatography, with a variety of 
essential oils (EOs) that contained 
beneficial therapeutic properties. 
Methods Results
Purpose
● The intention of this comprehensive and 
systematic review was to identify EOs that 
possess therapeutic effects on melanoma cells. 
● These EOs could be considered as a possible 
adjuvant or alternative therapy to enhance 
treatment efficiency and quality of life in 
Melanoma patients.
● In conclusion, the results of our cross sectional 
analysis showed that EOs can possess  
therapeutic effects on melanoma cells as an 
alternative or adjunct therapy to current 
treatments.
● The results collected in this study will contribute 
insight into potential EO formulations that can be 
considered as a form of treatment for melanoma 
compared to today’s current therapies.
● Future analysis will be performed on collected 
EOs to determine the most predominant qualities 
of decreasing inflammation and the apoptosis of 
melanoma cells. 
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Results
● Based on the collection of EO therapeutic 
properties and benefits, we selected three EOs 
commonly found within several articles: 
Melaleuca alternifolia1 , Achillea millefolium2, 
and Salvia rubifolia3.
● Each of these three EOs demonstrated different 
characteristics leading to several therapeutic 
effects in the treatment of Melanoma cells.
● Melaleuca alternifolia1 and Salvia rubifolia3 EOs 
both  induced apoptosis in the human Melanoma 
cell lines tested.
● Achillea millefolium2 showed to inhibit 
melanogenesis in the human Melanoma cell lines 
tested.
Melaleuca Alternifolia 




Cell Lines Human Melanoma M14 WT 
cells
M14 adriamycin-resistant cells
HEp-2 melanoma cell lines
Human Melanoma M14 cells
SK-MEL Variants
Human Melanoma M14 cells
Molecular Mechanism Caspase
cytotoxicity induced  apoptosis
P53 upregulation, providing 
tumor suppression
Pax Gene Inhibition, 
decreasing the growth of 
melanoma tissues
BCL-2 downregulation 
induced inhibition of cell cycle 
phases G2 and M
Targets BRAF mutation of 
melanoma cells to inhibits 
melanogenesis 




Induced apoptosis, releasing 
LDH and cytotoxic substrates 
into surrounding medium
DNA damage shown by 
increased TDNA and TMOM 
concentrations from COMET 
assay
Major Constituents Terpinen-4-ol (42.35%)
G-terpinene (20.65%)
 A-terpinene  (9.76%)










● Out of the 30 articles, a cross-sectional 
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